Get notified when HCWB files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Will Not Be Exercisable and Therefore Have No Value (new) — The warrants are contingent on shareholder approval, and if not obtained, they become worthless.
NASDAQ: HCWB HCW Biologics Inc. 424B4

HCW Biologics prices $1.5M unit offering at $0.6055 per unit; warrants contingent on shareholder approval

Filed February 19, 2026 · ~1 min read

Key Changes

  • high

    HCW Biologics is offering 2,477,292 units at $0.6055 each, each unit consisting of one share and one warrant, for gross proceeds of about $1.5 million.

    The Offering verify on EDGAR →
  • high

    The warrants are exercisable only after shareholder approval, at $0.6055 per share, expiring five years after approval; if approval is not obtained, the warrants have no value.

    The Offering verify on EDGAR →
  • medium

    The offering is primary, so all proceeds go to the company.

    The Offering verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (CBRL 10-K) is open in full — no account needed.

Partner

Trade HCWB commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify